Neuro-endocrine cells--a new prognostic parameter in prostate cancer - PubMed (original) (raw)
Neuro-endocrine cells--a new prognostic parameter in prostate cancer
R J Cohen et al. Br J Urol. 1991 Sep.
Abstract
Neuro-endocrine cells are a recognised component of prostatic ducts and acini. Half of all clinically manifest cancers show neuro-endocrine differentiation. Occult carcinomas have a lower incidence of such differentiation. Neuro-endocrine cells are of major prognostic importance and appear more reliable in predicting patients' survival than do conventional histological grading systems.
Similar articles
- Prostatic carcinoma: histological and immunohistological factors affecting prognosis.
Cohen RJ, Glezerson G, Haffejee Z, Afrika D. Cohen RJ, et al. Br J Urol. 1990 Oct;66(4):405-10. doi: 10.1111/j.1464-410x.1990.tb14963.x. Br J Urol. 1990. PMID: 2224434 - Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
Bonkhoff H, Stein U, Remberger K. Bonkhoff H, et al. Hum Pathol. 1995 Feb;26(2):167-70. doi: 10.1016/0046-8177(95)90033-0. Hum Pathol. 1995. PMID: 7532147 - Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
di Sant'Agnese PA. di Sant'Agnese PA. Urology. 1998 May;51(5A Suppl):121-4. doi: 10.1016/s0090-4295(98)00064-8. Urology. 1998. PMID: 9610566 Review. - Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?
Allen FJ, Van Velden DJ, Heyns CF. Allen FJ, et al. Br J Urol. 1995 Jun;75(6):751-4. doi: 10.1111/j.1464-410x.1995.tb07385.x. Br J Urol. 1995. PMID: 7613832 - Prognostic significance of neuroendocrine differentiation in prostate cancer.
Ather MH, Abbas F. Ather MH, et al. Eur Urol. 2000 Nov;38(5):535-42. doi: 10.1159/000020352. Eur Urol. 2000. PMID: 11096233 Review. No abstract available.
Cited by
- Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Kaur H, Samarska I, Lu J, Faisal F, Maughan BL, Murali S, Asrani K, Alshalalfa M, Antonarakis ES, Epstein JI, Joshu CE, Schaeffer EM, Mosquera JM, Lotan TL. Kaur H, et al. Prostate. 2020 Sep;80(12):1012-1023. doi: 10.1002/pros.24035. Epub 2020 Jul 10. Prostate. 2020. PMID: 32649013 Free PMC article. - Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.
Priemer DS, Montironi R, Wang L, Williamson SR, Lopez-Beltran A, Cheng L. Priemer DS, et al. Endocr Pathol. 2016 Jun;27(2):123-35. doi: 10.1007/s12022-016-9421-z. Endocr Pathol. 2016. PMID: 26885643 Review. - Neuroendocrine differentiation of prostate cancer: a review.
Parimi V, Goyal R, Poropatich K, Yang XJ. Parimi V, et al. Am J Clin Exp Urol. 2014 Dec 9;2(4):273-85. eCollection 2014. Am J Clin Exp Urol. 2014. PMID: 25606573 Free PMC article. Review. - Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.
Dirican A, Atmaca H, Bozkurt E, Erten C, Karaca B, Uslu R. Dirican A, et al. Clin Transl Oncol. 2015 Feb;17(2):145-51. doi: 10.1007/s12094-014-1206-6. Epub 2014 Jul 25. Clin Transl Oncol. 2015. PMID: 25060568 - Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA. Epstein JI, et al. Am J Surg Pathol. 2014 Jun;38(6):756-67. doi: 10.1097/PAS.0000000000000208. Am J Surg Pathol. 2014. PMID: 24705311 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical